Deluxe Family(SH:600503) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-08-21 01:37Core Viewpoint - The stock of Huayi Family Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price deviation exceeding 20% over two consecutive trading days on August 19 and 20, 2025 [2][4]. Group 1: Stock Trading Abnormality - The stock price deviation of Huayi Family Co., Ltd. exceeded 20% over two consecutive trading days, which is significant under the Shanghai Stock Exchange trading rules [2][4]. - If the stock price deviation exceeds 20% for three consecutive trading days, it will be classified as an abnormal trading fluctuation [4]. Group 2: Company Verification and Operations - The company conducted a self-examination and confirmed that its production and operations are normal, with no significant changes in the internal and external environment [5]. - There are no undisclosed major operational information or events that could impact the stock price, including major asset restructuring or significant transactions [6]. Group 3: Media Reports and Market Rumors - Aside from the announcement regarding cash injection into Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. on August 11, 2025, no other media reports or market rumors have been identified that could significantly affect the stock price [7]. Group 4: Shareholding and Pledge Information - As of the announcement date, the controlling shareholder, Shanghai Nanjing (Group) Co., Ltd., holds 114,020,000 shares, accounting for 7.12% of the total share capital, with 90,075,800 shares pledged, representing 5.62% of the total share capital [10]. Group 5: Financial Performance - The company expects a net loss attributable to shareholders of the parent company in the range of -12.5 million to -8.35 million yuan for the first half of 2025, indicating a shift from profit to loss compared to the previous year [11].